Telix Doses First Patient in European TLX250-CDx Trial

1 year ago 35

Telix (ASX:TLX) has announced that the first patient has been dosed in an early access program in the Netherlands for its investigational positron

1. Homepage
2. category-label-
3. Telix Doses First Patient in European TLX250-CDx Trial